Replies to post #47 on Amplia Therapeutics Ltd. (INNMF)

[BC239]

I think it would have if they didn't give the CEO 500,000 options. That kind of dilution can just take the wind out of the sails.
The last 2B patient should be done. I hope they put out a PR soon with some data regarding that. More than once they have stated the percentage of MIS416 users who have asked to stay on it. They must have updated info on that.
Their data will also be presented at the big neurological get together in Boston next week. I hope they're smart enough to exploit the results of those presentations as well.
To this point though, they haven't been much of a marketing machine. Info that gets released is sporadic at best.